Ozempic was originally approved by the FDA to treat people with type 2 diabetes who are at risk of serious health consequences without medication.  In recent months, there has been a spike in demand for Ozempic, or semaglutide, due to its weight-loss benefits, which has led to shortages.  Some doctors prescribe Ozempic off-label to treat obesity.

Michigan insurers seek premium hikes as demand for diet drugs soars

Michigan health insurers are looking to raise premiums again next year, with rising demand for expensive diabetes and weight-loss drugs like Ozempic and Wegovy contributing to what they see as needed rate hikes. A report from the Michigan Department of Insurance and Financial Services, which reviews and approves insurer rates, shows health insurance companies are …

Michigan insurers seek premium hikes as demand for diet drugs soars Read More »